HighTower Advisors LLC increased its holdings in Corteva, Inc. (NYSE:CTVA – Free Report) by 5.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 193,070 shares of the company’s stock after acquiring an additional 10,427 shares during the period. HighTower Advisors LLC’s holdings in Corteva were worth $12,941,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Activest Wealth Management grew its holdings in shares of Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares during the period. JPL Wealth Management LLC purchased a new position in shares of Corteva in the 3rd quarter valued at approximately $25,000. Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the 3rd quarter valued at approximately $29,000. Jackson Grant Investment Advisers Inc. boosted its position in shares of Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after purchasing an additional 213 shares in the last quarter. Finally, KERR FINANCIAL PLANNING Corp purchased a new stake in Corteva in the third quarter worth $33,000. Institutional investors own 81.54% of the company’s stock.
Corteva Trading Up 0.0%
NYSE:CTVA opened at $79.57 on Monday. The stock has a market cap of $53.22 billion, a price-to-earnings ratio of 46.81, a PEG ratio of 2.43 and a beta of 0.59. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The company’s 50 day moving average price is $81.33 and its 200-day moving average price is $74.04. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63.
Corteva Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, June 1st. Corteva’s payout ratio is currently 42.35%.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on CTVA. Weiss Ratings upgraded Corteva from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, May 7th. Mizuho upped their target price on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 15th. Oppenheimer increased their price target on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Wells Fargo & Company lifted their price target on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, April 21st. Finally, UBS Group boosted their price objective on shares of Corteva from $88.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Thirteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $88.14.
View Our Latest Stock Report on CTVA
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
